# Neuroprotection of Pioglitazone in Acute Ischemic Stroke

> **NCT02195791** · PHASE2 · TERMINATED · sponsor: **Taipei Medical University Shuang Ho Hospital** · enrollment: 4 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02195791
- **Lead sponsor:** Taipei Medical University Shuang Ho Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Diffculty in participant enrollment
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02195791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02195791, "Neuroprotection of Pioglitazone in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02195791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*